Hematology With Afaf E. Osman, MD

Oncology / Hematology

Dr. Osman is an assistant professor at the University of Utah Huntsman Cancer Institute where she treats myeloid malignancies. Her research interest is in myeloid precursor conditions including clonal hematopoiesis.

  • Afaf E. Osman, MD
    Oncology / Hematology

    Dear readers, I want to start this newsletter by thanking you for taking time from your busy schedules to read about the latest and greatest…

  • Afaf E. Osman, MD
    Oncology / Hematology
    MDS March - 2 month(s) ago

  • Afaf E. Osman, MD
    Oncology / Hematology
    MDS January - 3 month(s) ago

  • Afaf E. Osman, MD
    Oncology / Hematology

    Happy New Year everyone!  I hope 2024 brings exciting news for our patients with myelodysplastic syndromes (MDS), especially those with high-risk disease and TP53 mutations.…

  • Afaf E. Osman, MD
    Oncology / Hematology

    Hello, In less than a month, many of us will be in San Diego, California, for the American Society of Hematology (ASH) Annual Meeting and…

  • Afaf E. Osman, MD
    Oncology / Hematology

    Many clinicians adopted the newly introduced IPSS-M risk stratification model in their treatment of patients with Myelodysplastic Syndromes (MDS). Personal experience of implementing this model…

  • Afaf E. Osman, MD
    Oncology / Hematology

    Hi everyone,  This is the last email in my newsletter covering myelofibrosis and other hemaotlogic malignancies at #ASCO22.  The first article focuses on the MOMENTUM…